RACHEL HOINS: Open Payments
NPI 1154891299 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 9 payments from 7 companies in 2025. Trend: 2023 $271 · 2024 $273 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $119 |
| EMD Serono, Inc. | 1 | $107 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $93 |
| Lilly USA, LLC | 2 | $66 |
| UCB, Inc. | 2 | $33 |
| Genentech USA, Inc. | 1 | $29 |
| Averitas Pharma Inc. | 1 | $18 |
Products named: Symbravo, Mavenclad, KISUNLA, Fintepla, Ocrevus Zunovo, EMGALITY, QUTENZA.
Industry payments across MO — which companies pay providers there.
